Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.66 |
| ▸ | CA2 | P00918 | 3/20 | 0.66 |
| ▸ | CA12 | O43570 | 2/20 | 0.66 |
| ▸ | CA7 | P43166 | 2/20 | 0.66 |
| ▸ | CA9 | Q16790 | 2/20 | 0.66 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.66 |
| ▸ | ESR1 | P03372 | 1/20 | 0.66 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | MAOA | P21397 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 4/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11173844 | 0.92 | CA1 (0.61) | CA1CA2CA12CA7CA9 | |
| SCHEMBL28510538 | 0.88 | CA1 (0.66) | CA1CA2CA12CA7CA9 | |
| SCHEMBL87450 | 0.87 | CA1 (0.83) | CA1CA2CA12CA7CA9 | |
| SCHEMBL147669 | 0.86 | MEN1 (0.67) | CA1CA2CA12CA7CA9 | |
| SCHEMBL27667917 | 0.85 | CA1 (0.79) | CA1CA2CA12CA7CA9 | |
| SCHEMBL30271267 | 0.85 | CA1 (0.79) | CA1CA2CA12CA7CA9 | |
| SCHEMBL7746905 | 0.85 | CA1 (0.79) | CA1CA2CA12CA7CA9 | |
| SCHEMBL21440358 | 0.85 | CA1 (0.79) | CA1CA2CA12CA7CA9 | |
| SCHEMBL27647572 | 0.85 | CA1 (0.79) | CA1CA2CA12CA7CA9 | |
| SCHEMBL27667926 | 0.85 | CA1 (0.79) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8987516-B2 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
| EP-2468722-B1 | Process for producing arylsulfur halotetrafluorides | UBE INDUSTRIES (JP) | 2014-10-01 | — | — | EP | disclosed |
| EP-2468721-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2014-02-26 | — | — | EP | disclosed |
| EP-2468720-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-11-27 | — | — | EP | disclosed |
| EP-2468719-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-10-16 | — | — | EP | disclosed |
| EP-2137144-B1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | UBE INDUSTRIES (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-8399720-B2 | Methods for producing fluorinated phenylsulfur pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2013-03-19 | — | — | US | disclosed |
| EP-2479203-A1 | AROMATIC POLYESTER | Muroran Institute of Technology (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120172570-A1 | AROMATIC POLYESTER | NITTA CORPORATION | 2012-07-05 | — | — | US | disclosed |
| EP-2468722-A1 | Process for producing arylsulfur halotetrafluorides | UBE Industries, Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| US-7592491-B2 | Process for producing arylsulfur pentafluorides | IM&T RESEARCH, INC. (US) | 2009-09-22 | — | — | US | disclosed |
| WO-2008118787-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM & T RESEARCH, INC. (US) | 2008-10-02 | — | — | WO | disclosed |
| US-20080234520-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | IM&T RESEARCH, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| US-6114339-A | TREATING PNEUMOCYSTIS AND TOXOPLASMOSIS | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 2000-09-05 | — | — | US | disclosed |
| US-5866580-A | TREATING AN ILLNESS CAUSED BY P. CARINII AND T. GONDII | DUGUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1999-02-02 | — | — | US | disclosed |
| US-5736547-A | RESISTS PNEUMOCYSTIS CARNII AND TOXOPLASMOSIS GONDII INFECTIONS IN IMMUNOCOMPROMISED PATIENTS; DIHYDROFOLATE REDUCTASE INHIBITORS; AIDS; ANTITUMOR AGENTS; SYNERGISTIC AGENT WITH SULFA DRUGS | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1998-04-07 | — | — | US | disclosed |
| US-5508281-A | TREATING ILLNESS CAUSED BY PNEUMOCYSTIS CARINII OR TOXOPLASMOSIS GONDII | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1996-04-16 | — | — | US | disclosed |
| EP-0409382-A1 | Glutamic acid derivatives | THE WELLCOME FOUNDATION LIMITED (GB) | 1991-01-23 | — | — | EP | disclosed |
| WO-1990014340-A1 | GLUTAMIC ACID DERIVATIVES | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-11-29 | — | — | WO | disclosed |
| US-4921836-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1990-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234520-A1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | PFAS, MPST, ARSA | CA1 2632/4885CA2 3338/4885CA12 2357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.